Table: Sapporo Clinical Lab - 9-MTH group results

Sapporo Clinical Laboratory

10/02/2023 06:30

Feb 10 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2022        Dec 31, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             15.25               14.29            19.36    
                 (+6.8 pct)          (+10.0 pct)      (+1.3 pct)  
  Operating        816 mln               1.09             1.17    
                 (-24.8 pct)         (+45.2 pct)      (-24.2 pct) 
  Recurring        971 mln               1.14             1.11    
                 (-14.7 pct)         (+50.1 pct)      (-30.8 pct) 
  Net              493 mln             661 mln          714 mln   
                 (-25.5 pct)         (+36.9 pct)      (-31.5 pct) 
  EPS            147.85 yen          193.96 yen       213.01 yen  
  Ann Div                             23.00 yen        23.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             23.00 yen        23.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T